Safeguarding public health across Europe
European Medicines Agency (EMA) (europa.eu) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Government brands, in the 67th percentile of 22305 Healthcare brands.
The European Medicines Agency (EMA) is a decentralised agency of the European Union established in 1995. It is responsible for the scientific evaluation, supervision, and safety monitoring of medicines within the EU. EMA works to protect and promote public and animal health by ensuring medicines meet rigorous scientific standards before reaching patients. Its stakeholders include healthcare professionals, regulatory bodies, pharmaceutical companies, policymakers, and the general public across EU member states.
| Brand Name | European Medicines Agency (EMA) |
|---|---|
| Domain | europa.eu |
| Industry | Healthcare, Government |
| Founded | 1995 |
| Parent Company / Owner | European Union |
| Main Competitors | U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Health Canada (83/100), Pharmaceuticals and Medical Devices Agency (PMDA) (41/100), Therapeutic Goods Administration (TGA) (78/100), World Health Organization (WHO) Prequalification Programme (74/100) |
Moz Domain Authority 97/100 vs category average 40 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
European Medicines Agency (EMA) appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Drupal.
Social footprint: verified profiles on YouTube, Facebook, Instagram; no detected presence on LinkedIn, X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is European Medicines Agency (EMA)?", Claude could identify the brand as of November 2026. The European Medicines Agency is a decentralized agency of the European Union responsible for the scientific evaluation, supervision, and safety monitoring of medicines developed and marketed within the EU. It coordinates with national regulatory bodies to assess drug application Best known for Being the EU's central regulatory body for evaluating and approving medicines, similar in role to the FDA in the US.
When asked "Best brands similar to European Medicines Agency (EMA)?", Claude would recommend European Medicines Agency (EMA) as of November 2026. It's the key regulatory authority for pharmaceuticals in Europe, so it's directly relevant if someone asks about major drug regulatory agencies or health authorities.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
European Medicines Agency (EMA)'s main competitors in Healthcare: U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Health Canada (83/100), Pharmaceuticals and Medical Devices Agency (PMDA) (41/100), Therapeutic Goods Administration (TGA) (78/100).
Sources: Brand Analyzer scan
The European Medicines Agency (EMA) is a decentralised agency of the European Union, founded in 1995, responsible for the scientific evaluation, supervision, and safety monitoring of medicines used within the EU. It operates as a regulatory body under the European Union, working to ensure that medicines meet established standards of safety, efficacy, and quality before they are authorized for use in EU member states.
European Medicines Agency (EMA) has moderate AI-search visibility, scoring 50/100 on Brand Analyzer's AI visibility composite (visibility 35, trust 54, recommendation 71). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
European Medicines Agency (EMA) was founded in 1995. European Medicines Agency (EMA) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
European Medicines Agency (EMA) scores 71/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
EMA provides scientific evaluation services for medicines seeking EU-wide marketing authorization, ongoing safety monitoring and pharmacovigilance for approved medicines, and regulatory guidance and scientific advice to pharmaceutical companies and policymakers. It also disseminates information to healthcare professionals and the public regarding medicine safety and efficacy.
As an official decentralised agency of the European Union established in 1995, EMA operates within a formal regulatory and governmental framework to evaluate, supervise, and monitor the safety of medicines. Its role as the authoritative EU body for medicine regulation, grounded in scientific assessment, supports its position as a credible and trustworthy institution for ensuring public and animal health standards across the EU.
European Medicines Agency (EMA) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
EMA's services and outputs are used by healthcare professionals, regulatory bodies, pharmaceutical companies, policymakers, and the general public across the European Union. Pharmaceutical companies rely on EMA for marketing authorization evaluations, while healthcare professionals and the public use its safety information to make informed decisions about medicines.
EMA is known for its role as the central EU authority conducting scientific evaluations of medicines before they are authorized for use across EU member states. It is also recognized for its ongoing safety monitoring of medicines and its coordination with national regulatory bodies to protect public and animal health.
European Medicines Agency (EMA) is owned by or part of European Union. European Medicines Agency (EMA) operates in the Healthcare category.
Sources: Wikidata
European Medicines Agency (EMA) scores 50/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
European Medicines Agency (EMA) has a limited AI-visibility profile at 50/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (71/100) and its weakest is visibility (35/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 97/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify European Medicines Agency (EMA) from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
78 in November 2026, up from 55 in October 2026.
Ranked closest to European Medicines Agency (EMA): Eugenix Hair Sciences (78/100), Eugenix Hair Sciences (78/100), European Pharmaceutical Review (78/100), Every Mother Counts (78/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.